Pharmacokinetics of HMS-01 in rats
10.12206/j.issn.1006-0111.201907036
- VernacularTitle:HMS-01在大鼠体内的药动学研究
- Author:
Yu ZHANG
1
;
Zhen QIN
1
;
Yang SUN
1
;
Jiaguo LÜ
1
;
Fang WU
2
;
Xia LIU
1
Author Information
1. Department of Clinical Pharmacology, School of Pharmacy, Naval Medical University, Shanghai 200433, China.
2. Qinshen Jiahe Pharmaceutical Research Co., Ltd, Xi'an 710068, China.
- Keywords:
HMS-01;
pharmacokinetics;
rats;
plasma;
LC-MS/MS method
- From:
Journal of Pharmaceutical Practice
2020;38(3):237-240
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the pharmacokinetics of HMS-01 in rats and provide support for subsequent study. Methods A sensitive and specific method for the determination of HMS-01 in plasma and other biological samples was established by LC-MS/MS. The pharmacokinetics of HMS-01 in rats was studied by the established method. The pharmacokinetics of one dose of single intragastric administration and one dose of single intravenous administration in SD rats were studied, and the basic pharmacokinetic parameters were obtained. Results After intravenous injection of 1 mg/kg HMS-01, the area under the plasma concentration-time curve AUC0-t of male and female rats was 221 ng·h/ml and 409 ng·h/ml, respectively. The average clearance rates were 4.53 L/h·kg and 2.41 L/h·kg, respectively. The average plasma elimination half-lives were 0.786 h and 1.27 h, and the apparent distribution volume was 5.13 L/kg and 3.82 L/kg, respectively. After intragastric administration of 30 mg/kg HMS-01, the peak time of plasma concentration in rats was 1.17 h, the peak concentration of Cmax was 1 243 ng/ml, and the elimination half-life t1/2 was 2.00 h. The AUC0-t of male and female rats was 2 271 and 8 529 ng·h/ml respectively, and their bioavailability was 34.3% and 69.5% respectively. Conclusion The pharmacokinetics of HMS-01 in rats has significant gender differences. It is well absorbed orally, and the bioavailability of HMS-01 in females is much higher than that in males.
